Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03886259
Other study ID # N-20180046
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date April 8, 2024

Study information

Verified date May 2024
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate whether a 12-week neuromuscular rehabilitation program (NEMEX-TJR) combined with pain neuroscience education (PNE) provides greater pain relief, improvement in physical function and quality of life than PNE alone in a population of patients with chronic pain after primary total knee arthroplasty. Hypothesis: Rehabilitation involving neuromuscular training and PNE will provide greater pain relief, improved function and improved quality of life compared to PNE alone at the primary endpoint, which is follow-up 12months after the start of the treatment.


Description:

Osteoarthritis is considered the most frequent cause of disability and pain in the elderly population, and the knee joint is one of the joints most commonly affected. End-stage osteoarthritis is often treated with knee replacement, and total knee arthroplasty is considered an effective treatment for pain relief and improved function. However, several studies have reported less favorable outcomes after total knee arthroplasty, and systematic reviews found chronic pain after total knee arthroplasty at 12 months post-operative in 13-17% of the patients and chronic pain rates at 2-7 years post-operative varying between 8-27%. No randomized controlled trials evaluating exercise and pain education treatments to patients with chronic pain after total knee arthroplasty exists, and this highlights the need for evidence-based knowledge of which treatment should be considered for this population.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date April 8, 2024
Est. primary completion date February 21, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Body Mass Index (BMI) between 19-40 - Subjects with primary total knee arthroplasty due to osteoarthritis = 12 months post-operatively - For the index knee, duration of knee pain > 6 months - For the index knee, the average daily pain score = 4 (moderate-to-severe pain) over the last week prior to visit on a numeric rating scale Exclusion Criteria: - Specific reasons for chronic pain, such as loosening of implant, which requires revision surgery - Secondary causes of arthritis to the knee, e.g. rheumatoid arthritis - Surgery (including arthroscopy) of the index knee within 3 months prior to visit - Injury to the index knee within 12 months prior to visit - Recent history of acute pain affecting the lower limb and/or trunk - Participation in other pain trials two weeks prior to this study - Pregnancy - Drug and alcohol abuse - Previous neurologic illnesses or primary pain area other than knee, e.g. lower back, upper extremity pain or rheumatoid arthritis - Lack of ability to adhere to protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neuromuscular exercises (NEMEX-TJR) and pain neuroscience education
60min. of neuromuscular exercises (NEMEX-TJR) training two times a week for 3 months (12 weeks, 24 sessions). Physiotherapists will instruct and supervise the participants during the neuromuscular exercises. The aim of the neuromuscular exercise program is to restore normal movement, improve sensorimotor control, re-establishing normal motor program strategies and muscle activation. 60min. of pain neuroscience education at the beginning of intervention period and after 6 weeks. Both sessions will take 60min. and will be conducted by physiotherapists. The aim of the pain neuroscience education is to increase the pain neuroscience knowledge of the patients leading to a better understanding of their chronic pain and thereby engaging the patients in the treatment of their chronic pain and impaired function.
Pain neuroscience education
60min. of pain neuroscience education at the beginning of intervention period and after 6 weeks. Both sessions will take 60min. and will be conducted by physiotherapists. The aim of the pain neuroscience education is to increase the pain neuroscience knowledge of the patients leading to a better understanding of their chronic pain and thereby engaging the patients in the treatment of their chronic pain and impaired function.

Locations

Country Name City State
Denmark Department of Occupational and Physiotherapy, Aalborg University Hospital Aalborg
Denmark Department of Occupational- and Physiotherapy, Aalborg University Hospital Farsø
Denmark Department of Occupational- and Physiotherapy, Aalborg University Hospital Thisted

Sponsors (5)

Lead Sponsor Collaborator
Aalborg University Lions Denmark, Northern Orthopaedic Division, Denmark, Svend Andersen Foundation, The Danish Rheumatism Association

Country where clinical trial is conducted

Denmark, 

References & Publications (10)

Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012 Feb 22;2(1):e000435. doi: 10.1136/bmjopen-2011-000435. Print 2012. — View Citation

Beswick AD, Wylde V, Gooberman-Hill R. Interventions for the prediction and management of chronic postsurgical pain after total knee replacement: systematic review of randomised controlled trials. BMJ Open. 2015 May 12;5(5):e007387. doi: 10.1136/bmjopen-2014-007387. — View Citation

Bhave A, Mont M, Tennis S, Nickey M, Starr R, Etienne G. Functional problems and treatment solutions after total hip and knee joint arthroplasty. J Bone Joint Surg Am. 2005;87 Suppl 2:9-21. doi: 10.2106/JBJS.E.00628. No abstract available. — View Citation

Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ. Knee replacement. Lancet. 2012 Apr 7;379(9823):1331-40. doi: 10.1016/S0140-6736(11)60752-6. Epub 2012 Mar 6. — View Citation

Davidson D, de Steiger R, Graves S, Tomkins A et al. Australian orthopaedic association national joint replacement registry. annual report. Adelaide:AOA;2010. . 2010

Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005 Mar 12-18;365(9463):965-73. doi: 10.1016/S0140-6736(05)71086-2. — View Citation

Larsen JB, Skou ST, Arendt-Nielsen L, Simonsen O, Madeleine P. Neuromuscular exercise and pain neuroscience education compared with pain neuroscience education alone in patients with chronic pain after primary total knee arthroplasty: study protocol for the NEPNEP randomized controlled trial. Trials. 2020 Feb 24;21(1):218. doi: 10.1186/s13063-020-4126-5. — View Citation

Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001 Feb;60(2):91-7. doi: 10.1136/ard.60.2.91. — View Citation

Wylde V, Dennis J, Beswick AD, Bruce J, Eccleston C, Howells N, Peters TJ, Gooberman-Hill R. Systematic review of management of chronic pain after surgery. Br J Surg. 2017 Sep;104(10):1293-1306. doi: 10.1002/bjs.10601. Epub 2017 Jul 6. — View Citation

Wylde V, Dieppe P, Hewlett S, Learmonth ID. Total knee replacement: is it really an effective procedure for all? Knee. 2007 Dec;14(6):417-23. doi: 10.1016/j.knee.2007.06.001. Epub 2007 Jun 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Hospital Anxiety and Depression Scale The questionnaire consists of 14 items, which measures the patient level of anxiety and depression. The score in each item ranges from 0-3, giving scoring ranges from 0-21. Baseline
Primary Change in Knee Injury and Osteoarthritis Outcome Score4 (KOOS4) from baseline to 12months follow-up The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be performed. Baseline and at 3, 6 and 12 months
Secondary Change in all five subscales of the KOOS All five domains, covering pain, symptoms, difficulties in functions of daily living, sport and recreation and quality of life of the questionnaire will be used as secondary outcome with scores ranging from 0 (worst) to 100 (best). Baseline and at 3, 6 and 12 months
Secondary Rating of Global Perceived Effect Global Perceived Effect will be assessed using the question: "How are your knee problems now compared with before you entered this study"? The question will be answered on a seven-point Likert scale ranging from 'Improved, an important improvement' to 'Worse, an important worsening'. 3, 6 and 12 months
Secondary Change in maximal pain intensity during rest (day and night), stair climbing, and walking on a Numeric Rating Scale (NRS) Pain intensities on a NRS, where "0" represents "no pain" and "10" represents "maximal pain" in various situations. Baseline and at 3, 6 and 12 months
Secondary Change in use of Pain Medication Dosage of pain medication used within last week Baseline and at 3, 6 and 12 months
Secondary Number of adverse events related to interventions Serious and non-serious events that may occur during the intervention period will be identified in different ways: by self-reporting by the participants and by observation from the physiotherapists. Adverse events will be categorized as occurring in the index knee or other sites than the index knee. 3 months
Secondary Change in 40-meter fast-paced walk test The amount of time in seconds it takes to complete the 40m Baseline and at 3, 6 and 12 months
Secondary Change in stair climb test The amount of time in seconds it takes to complete ascending and descending of 9 stairs Baseline and at 3, 6 and 12 months
Secondary Change in 30-second chair stand test Number of repetitions in 30-seconds Baseline and at 3, 6 and 12 months
Secondary Change in PainDETECT scores The questionnaire is comprised of 3 major components: graduation of pain, pain course pattern and radiating pain. The maximum possible score is 38, and the minimum possible score is -1. Baseline and at 3, 6 and 12 months
Secondary Change in score from the Fear-avoidance Beliefs Questionnaire - Physical Activity The scores range from "0" with "completely disagree" to "6" with "completely agree" and sums up to a total score between 0-24. Baseline and at 3, 6 and 12 months
Secondary Change in score from the Pain Catastrophizing Scale Scores is rated on a 5-point scale with the 0 being "not at all" and 4 being "all the time" and the score can range from 0 to 52 points. Baseline and at 3, 6 and 12 months
Secondary Change in pinprick hyperalgesia at index knee and extrasegmental The subject is to rate the pain intensity from the pinprick on a NRS, where "0" represents "no pain" and "10" represents "maximal pain". Baseline and at 3, 6 and 12 months
Secondary Change in temporal summation at index knee and extrasegmental The subject is to rate the pain intensity of the last test stimulus on a NRS, where "0" represents "no pain" and "10" represents "maximal pain". Baseline and at 3, 6 and 12 months
Secondary Change in dynamic mechanical allodynia at the index knee and extrasegmental The subject is to rate the pain intensity of a cotton swab on a NRS, where "0" represents "no pain" and "10" represents "maximal pain". Baseline and at 3, 6 and 12 months
Secondary Change in deep somatic hyperalgesia at the index knee and extrasegmental A "bedside algometer" will be applied on the skin over the vastus medialis muscle on the index side. The subject is to indicate immediately when the pressure becomes painful. Baseline and at 3, 6 and 12 months
Secondary Change in pressure pain thresholds at the index knee and extrasegmental Pressure pain thresholds measured using a handheld algometer (Algometer Type II, Somedic AB, Hoerby, Sweden)) at the index knee and extrasegmental. Baseline and at 3, 6 and 12 months
Secondary Change in descending pain control Conditioned pain modulation effect will be measured comparing the test stimuli without conditioning stimuli to the test stimuli with conditioning stimuli Baseline and at 3, 6 and 12 months
Secondary Change in number of sites with usual pain shaded on a body chart Shaded markings on a body chart to indicate where usual pain is located Baseline and at 3, 6 and 12 months
Secondary Change in leg extension power Leg extension power in a single-leg simultaneous hip and knee extension will be measured bilaterally. Highest measurement in watt is the outcome. Baseline and at 3, 6 and 12 months
Secondary Change in isometric muscle strength of knee extensors and flexors Maximum isometric muscle strength (measured in Newtons) measured bilaterally in knee flexion and knee extension in a test using a handheld dynamometer (Lafayette manual muscle tester from Lafayette Instruments, USA). Baseline and at 3, 6 and 12 months
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain